Cefalexin for UTIs – Right treatment Length in Young children
Eligibility
Local study conflicts
Cannot enrol if patient is on any other drug trial
Inclusion Criteria: (all criteria must apply)
Age 3 months to 11 years inclusive
Clinical diagnosis of febrile UTI at presentation to ED as defined by BOTH:
Temperature ≥38°C measured by any method or likely fever in the last 24 hours
Clinical feature(s) suggestive of UTI at presentation – at least one symptom:
Under two years old:
Poor feeding
Vomiting
Irritability
Over two years old:
Vomiting
Dysuria
Urinary frequency
Urinary urgency
Abdominal or flank pain
Suprapubic or flank tenderness
Early urine test suggesting likely UTI as defined by any one of the following:
Dipstick: nitrite positive AND leucocyte esterase positive.
Dipstick: nitrite positive AND leucocyte esterase negative (on a fresh urine sample).
Dipstick: leucocyte esterase positive AND nitrite negative AND the treating clinician assesses there to be good clinical evidence of a UTI (e.g. obvious urinary symptoms).
Abnormal urine microscopy (bacteriuria by microscopy with Gram stain)
Decision to treat with oral cefalexin
Plan for discharge from the ED
Able to give written informed consent and use the App
Exclusion Criteria:
Known congenital anomalies of the kidney and urinary tract (CAKUT), reflux nephropathy or indwelling catheter
Known immune deficiency or currently receiving immunosuppression therapy
Systemic antibiotics for any reason (treatment or prophylaxis) in the previous 14 days
Weight > 50kg
Known allergy to cefalexin or previous severe allergic reaction to any beta-lactam antibiotic
The patient is on any other drug trial
If the patient is eligible:
Step by Step Guide to Recruitment:
In standard working hours; 9-5
Please contact the ED Research Team when eligible patients arrive in ED:
Send the ED Research Team a message via Epic chat "ED research Team" or phone 217907
Out of hours and weekends:
We are not planning to recruit OOH for the foreseeable future